跳至主要内容
临床试验/EUCTR2005-001930-34-DK
EUCTR2005-001930-34-DK进行中(未招募)不适用

eft ventricular reverse remodelling after aortic valve replacement in severe valvular aortic stenosis - effect of blockade of the angiotensin-II receptor

Department of Cardiology, Odense University Hospital0 个研究点开始时间: 2005年11月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria
  • 1.Symptomatic severe AVS referred for valve replacement (mechanic prosthesis or bioprosthesis) at Odense University Hospital
  • 2.Age > 18 years
  • 3.Signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria
  • 1.Severe renal failure (s-creatinine >300 mmole/l)
  • 2.Moderate or severe hepatic failure (ALAT >150 IU/l)
  • 3.Moderate or severe LV systolic dysfunction (LVEF<40%)
  • 4.Known intolerance for angiotensin II receptor antagonist (Atacand)
  • 5.Unwilling to participate in the study
  • 6.Poor echocardiographic window
  • 7. Women of childbearing potential (only postmenopausal women)

研究者

发起方
Department of Cardiology, Odense University Hospital

相似试验

eft ventricular reverse remodelling after aortic... | 临床试验